Glenmede Trust’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Glenmede Trust’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,000	Closed	-$41K	–	2948
2015 Q2	$41K	Hold	1,000	–	–	﹤0.01%	1705
2015 Q1	$35K	Hold	1,000	–	–	﹤0.01%	1786
2014 Q4	$32K	Hold	1,000	–	–	﹤0.01%	1886
2014 Q3	$28K	Buy	+1,000	New	+$30.5K	﹤0.01%	1860
2014 Q1	–	Sell	-312,279	Closed	-$7.97M	–	2434
2013 Q4	$7.97M	Sell	312,279 -48,165	-13%	-$1.48M	0.08%	316
2013 Q3	$10.5M	Buy	360,444 +47,969	+15%	+$1.33M	0.13%	214
2013 Q2	$8.98M	Buy	+312,475	New	+$8.61M	0.11%	201

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Glenmede Trust's BRLI Position: Q3 2015 in Review

Glenmede Trust sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 1,000 shares — an estimated $41K sold.

Glenmede Trust first reported a position in BRLI in Q2 2013 and held it in 7 quarters. The position peaked at $10.5M in Q3 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Glenmede Trust reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Glenmede Trust sold 1,000 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $41K.
Glenmede Trust first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 7 quarters.
Glenmede Trust's BIO-REFERENCE LABS INC-NEW- position peaked at $10.5M in Q3 2013.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Glenmede Trust's 13F filing for Q3 2015, filed 12 Nov 2015.